ASGCT 2020
  • Registration
    • COVID-19
    • FAQs
    • Media
  • Abstracts
    • Call for Abstracts
    • Submission and Presentation Information
    • Award Recipients
    • Abstract Topic Categories
    • Embargo Policy
    • Awards and Incentives
    • Disclosure Slide Template
  • Hotel & Travel
  • Program
    • Pre-Meeting Workshops
    • Schedule & App
    • Plenary Speakers
    • Disclosure Slide Template
    • PDF Program
  • Exhibitors & Sponsors
    • Exhibitor, Sponsor, and Advertiser Prospectus
      • PDF
    • Current Exhibitors & Sponsors
    • COVID-19
  • Media
    • Registration
    • Media Policy
  • Contact Us
  • www.asgct.org
Quick Links
  • ASGCT.org

Connect with us

ASGCT 2020

  • Registration
    • COVID-19
    • FAQs
    • Media
  • Abstracts
    • Call for Abstracts
    • Submission and Presentation Information
    • Award Recipients
    • Abstract Topic Categories
    • Embargo Policy
    • Awards and Incentives
    • Disclosure Slide Template
  • Hotel & Travel
  • Program
    • Pre-Meeting Workshops
    • Schedule & App
    • Plenary Speakers
    • Disclosure Slide Template
    • PDF Program
  • Exhibitors & Sponsors
    • Exhibitor, Sponsor, and Advertiser Prospectus
    • Current Exhibitors & Sponsors
    • COVID-19
  • Media
    • Registration
    • Media Policy
  • Contact Us
  • www.asgct.org
×

Submission and Presentation Information

There is no fee to submit an abstract and free registration for the Annual Meeting will be given to Associate Members who are first and presenting author of an abstract. Approximately 25 percent of the abstracts submitted will be eligible for oral presentation based on the review scores. All accepted abstracts will be published in the May supplement to Molecular Therapy.

Submission Information

Eligibility

  • ASGCT Members and non-Members are eligible to submit an abstract.
  • Submitting an abstract does not register you for the meeting. You must register for the meeting to present your abstract.

Ineligibility

  • Papers that have been accepted for publication or published prior to the abstract submission deadline may not be submitted unless special consideration is requested.
  • If your abstract was previously accepted for presentation at ASGCT or another national/international meeting, do not submit the abstract unless special permission is requested and granted from ASGCT.

International Abstract Submitters

International abstract submitters who plan to attend the ASGCT 23rd Annual Meeting will need to apply for a VISA. The amount of time required to obtain a VISA has increased tremendously, so please apply early. Abstract submitters can generate invitation letters online.

If you need assistance obtaining your letter of invitation, please contact Alex Peterson at the ASGCT Office.

Notification of Abstract Acceptance

Notification regarding acceptance of abstracts will be delivered via email on April 6, 2020. Meritorious Abstract Travel Awards, Excellence in Research Awards, and Underrepresented Minority Travel Awards acceptance and letters will also be sent at this time.

Acceptance of Presentation

All notified abstract presenters are required to accept their presentation as instructed in their notification email. This can be done online through the abstract submission site.

Late Breaking Abstract Submissions

ASGCT will not be accepting Late Breaking Abstract submissions for the 23rd Annual Meeting.

Abstract Questions

For all questions regarding the abstract submission process, please contact Coe-Truman Technologies’ Technical Support by phone at 1-217-398-1792 or by email at asgct@support.ctimeetingtech.com. If you would like to make changes to your abstract after submitting, you will now be able to return directly to your abstract and make changes until the deadline.

Presentation Information

Oral Abstract Presentations

Approximately 25 percent of accepted abstracts are scheduled as oral abstract presentations. Oral abstract presentations are formal PowerPoint presentations given during simultaneous oral abstract sessions lasting an hour and 45 minutes. Presentations are 10 minutes in length followed by five minutes of Q&A. Presenters are required to disclose any potential conflicts at the beginning of their presentation.

Poster Presentations

Sixty percent of all abstracts presented at the Annual Meeting occur during one of three poster sessions.

Poster sessions allow the presenter to illustrate the abstract on a poster board and discuss the abstract with attendees present at the poster session. Posters should acquaint conference participants with the fundamentals of the presenter's program, project, or study quickly and easily. Authors must be present during the entirety of the hourlong poster session in which their abstract has been assigned.

 

Important Dates

Abstract Notifications Sent
April 6, 2020

Abstracts Released
April 28, 2020

23rd ASGCT Annual Meeting
May 12 – 15, 2020

Download the #ASGCT20 App

Use the ASGCT app on your mobile device to build your schedule, read the abstracts (released on April 28), and guide your way through the Hynes Convention Center.

Hynes Convention Center
900 Boylston St.
Boston, MA 02115


Sponsors

Diamond

ASGCT AM20

Platinum

ASGCT AM20
ASGCT AM20
ASGCT AM20
ASGCT AM20

View Exhibitors & Sponsors »

American Society of Gene & Cell Therapy

Office

American Society of Gene & Cell Therapy
555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823 USA
Tel: 414.278.1341
Fax: 414.276.3349
Email: info@asgct.org

Quick Links

  • ASGCT 2020 Homepage
  • Registration
  • Abstracts
  • Hotel & Travel
  • Program
  • Exhibitors & Sponsors
  • Media
  • Contact ASGCT

Follow Us

© 2020 American Society of Gene & Cell Therapy. All rights reserved.